ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,165, issued on Feb. 4, was assigned to Xencor Inc. (Pasadena, Calif.).
"Fc variants with altered binding to FcRn" was invented by Aaron Keith Chamberlain (San Diego), John R. Desjarlais (Pasadena, Calif.), Sher Bahadur Karki (Santa Monica, Calif.), Gregory Alan Lazar (Pacifica, Calif.), Jost Vielmetter (Pasadena, Calif.) and Sean C. Yoder (Santa Monica, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes."
The patent was filed on Dec. 13, 2021, under Application No. 17/549,...